Show notes
In this conversation, I will talk with Peter Llewellyn-Davies, CEO of Apeiron and President of Biotech Austria about the Future of Life Science Entrepreneurship and Investment in Europe.Topics we discuss in the show:The Development of the Life Science Eco-System in EuropeHow Family Offices Support Life Science Companies in EuropeHow to Translate Science into BusinessDoes Europe Have a Culture of Success?And much more...Who is the Expert in the show?Peter Llewellyn-Davies CEO of Apeiron Biologics President of Biotech Austria Shownotes:Video to the EpisodeTimestamps:(00:00) Opening(01:25) How did the Life Science Ecosystem Evolve?(03:22) The Biontech Success Story(04:10) How Did The Private and Publice Sector Evolve in Europe Since 2006?(05:49) What is Biotech Austria’s Mission?(07:00) How Many Members Does Biotech Austria Have in 2021?(09:10) Biotech Success Stories From Austria(11:40) Vienna, Austria, Local Life-Science-Eco-Systems and Biontech’s Success(13:45) Why is it a Great Decision to Start a Life Science Company in Austria?(16:26) Where Do Scientists Get Follow On Funding From?(18:30) How Helpful is the New European Investment Regulation for Foreign Investors?(21:00) Fundraising Challenges for Life Science Companies(24:00) Why Life Science Investments Are Attractive(25:50) How to Get in Touch With Biotech AustriaPodcast Links:Podcast Website: https://www.lifescienceget2gether.com/Community Partner: https://linktr.ee/lsg2gChristian Soschner: https://linktr.ee/soschnerLSG2G Twitter: https://twitter.com/LGet2getherLSG2G Linkedin: https://www.linkedin.com/company/life-science-get2getherPodcast Episodes: https://pod.link/1493847125Episodes on YouTube: https://www.youtube.com/playlist?list=PLlZfrwd6iXrQ3LIANISUpP22seS2CsCEVSupport the show (https://lsg2g.substack.com/subscribe?)
